Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-01-13
1990-01-23
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 71, 549264, 71 88, 514450, A61K 3170, C07H 1704, C07P31306
Patent
active
048958379
ABSTRACT:
There are disclosed novel avermectin .DELTA. 23,24-derivatives (also referred to as 23,24-dehydro compounds). The compounds are prepared by selective dehydration of avermectin A2 or B2 compounds. The avermectin compounds have utility as anti-parasitic agents and compositions for that use are also disclosed. The compounds are also highly potent insecticides against agricultural pests. The .DELTA. 23,24-avermectin compounds have increased activity relative to the A2 or B2 compounds.
REFERENCES:
patent: 4199569 (1980-04-01), Chabala et al.
patent: 4310519 (1982-01-01), Albers-Schonberg et al.
patent: 4550160 (1985-10-01), Mrozik
Mrozik Helmut
Waksmunski Frank S.
Lilling Herbert J.
Merck & Co. , Inc.
Peselev Elli
Pfeiffer Hesna J.
Rose David L.
LandOfFree
Avermectin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Avermectin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Avermectin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-645328